Beyza Bulutoglu, PhDPrincipal Scientist, Large Molecule Drug Discovery at Genentech
Dr. Bulutoglu pursued her master’s studies in Biomedical Engineering at Yale University followed by Ph.D. studies in Chemical Engineering at Columbia University. Following her postdoctoral appointment at the Center for Engineering in Medicine & Surgery, in affiliation with Harvard Medical School and Massachusetts General Hospital, she joined the Protein Chemistry Department within the Large Molecule Drug Discovery Organization at Genentech as a Principal Scientist.
Her graduate work focused on application-oriented protein engineering, where she engineered various domains, including enzymes and stimulus-responsive peptides, to serve as building blocks in biotechnology applications. She was awarded the NIH Ruth L. Kirschstein Fellowship during her postdoc and conducted studies in the areas of synthetic biology, genetic engineering, tissue and cellular engineering. At Genentech, she leads a protein engineering group focusing on the design and application of different modalities to discover and develop new therapies for patients.